Mediolanum International Funds Ltd grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 27.4% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 37,263 shares of the medical equipment provider's stock after buying an additional 8,013 shares during the quarter. Mediolanum International Funds Ltd's holdings in Intuitive Surgical were worth $18,327,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of ISRG. AlphaCore Capital LLC lifted its stake in shares of Intuitive Surgical by 4.2% in the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock valued at $235,000 after purchasing an additional 18 shares during the period. Accredited Investors Inc. lifted its stake in shares of Intuitive Surgical by 1.9% in the 4th quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider's stock valued at $543,000 after purchasing an additional 19 shares during the period. Second Line Capital LLC lifted its stake in shares of Intuitive Surgical by 3.4% in the 4th quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock valued at $302,000 after purchasing an additional 19 shares during the period. Colonial Trust Co SC lifted its stake in shares of Intuitive Surgical by 8.8% in the 4th quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider's stock valued at $128,000 after purchasing an additional 20 shares during the period. Finally, Crown Wealth Group LLC lifted its stake in shares of Intuitive Surgical by 4.8% in the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock valued at $218,000 after purchasing an additional 20 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.
Analysts Set New Price Targets
ISRG has been the subject of a number of research analyst reports. Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Robert W. Baird lowered their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. BTIG Research lifted their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research note on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft cut Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their price objective for the company from $515.00 to $440.00 in a research note on Monday, June 9th. Finally, Wall Street Zen upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $592.05.
Get Our Latest Stock Analysis on ISRG
Intuitive Surgical Stock Performance
Shares of ISRG stock traded up $2.92 during mid-day trading on Tuesday, hitting $496.87. The company's stock had a trading volume of 1,828,822 shares, compared to its average volume of 1,992,835. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The stock has a market cap of $178.12 billion, a price-to-earnings ratio of 69.30, a PEG ratio of 5.20 and a beta of 1.64. The business has a 50-day moving average price of $528.51 and a 200 day moving average price of $534.63.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same quarter in the previous year, the company posted $1.78 earnings per share. Intuitive Surgical's revenue was up 21.4% compared to the same quarter last year. Equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.
Insider Buying and Selling
In other Intuitive Surgical news, insider Gary S. Guthart sold 2,800 shares of the business's stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $495.24, for a total transaction of $1,386,672.00. Following the completion of the sale, the insider owned 18,520 shares of the company's stock, valued at approximately $9,171,844.80. The trade was a 13.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Mark Brosius sold 216 shares of the business's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president directly owned 907 shares of the company's stock, valued at $510,740.77. This represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 18,303 shares of company stock worth $9,180,778. Company insiders own 0.70% of the company's stock.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.